According to SIGA Technologies's latest financial reports the company's current earnings (TTM) are $83.62 M. an increase over its 2022 earnings that were of $44.13 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $83.62 M | 89.48% |
2022 | $44.13 M | -50.38% |
2021 | $88.94 M | 16.22% |
2020 | $76.52 M | 1268.64% |
2019 | $5.59 M | -98.69% |
2018 | $0.42 B | -1912.24% |
2017 | -$23.57 M | -7.91% |
2016 | -$25.6 M | -30.38% |
2015 | -$36.76 M | -82.62% |
2014 | -$0.22 B | 796.54% |
2013 | -$23.59 M | 5.18% |
2012 | -$22.43 M | -28.53% |
2011 | -$31.39 M | |
2009 | -$11.88 M | 35.95% |
2008 | -$8.74 M | 17.07% |
2007 | -$7.47 M | 9.58% |
2006 | -$6.82 M | 168.94% |
2005 | -$2.54 M | -71.48% |
2004 | -$8.88 M | 67.71% |
2003 | -$5.3 M | 57.35% |
2002 | -$3.37 M | 3.73% |
2001 | -$3.25 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | -$0.53 B | -721.97% | ๐บ๐ธ USA |
Novavax NVAX | -$0.53 B | -732.15% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | -$0.15 B | -269.86% | ๐บ๐ธ USA |
NanoViricides NNVC | -$9.36 M | -111.19% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | -$0.23 B | -370.54% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | -$0.65 B | -869.90% | ๐บ๐ธ USA |